Year: 2013
G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine
Year: 2013
An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.
Year: 2013
Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.
Year: 2013
The GMO Register entry provides significant details of the clinical trial
Year: 2013
Environmental Risk Assessment Dossier for Clinical Trial G0498-01
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received.
Year: 2013
Environmental Risk Assessment Dossier (in accordance with Schedule II, SI 500 of 2003) for proposed Clinical Trial G0498-01
Year: 2013
Conclusions on the potential environmental impact from the release or the placing on the market of genetically modified organisms, re G0498-01
Year: 2013
All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency
Year: 2013
An extract from the minutes of the EPA Board Meeting of 25 June 2013 at which the Centre for Cellular and Molecular Therapeutics' notification seeking consent to carry out a clinical trial at St James's Hospital Dublin was discussed
Year: 2013
G0498-01 Consent Condition issued to The Centre for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia, USA, on 3 July 2013 for a clinical trial using a Genetically Modified Organism (GMO) at St. James's Hospital Dublin
Year: 2013
Summary Notification Information Format for proposed Clinical Trial G0498-01
Year: 2013
Correspondence from Teagasc regarding 4 April 2012 and 23 May 2012 requests for further information
Year: 2013
Teagasc's response, dated 11 April 2012, to EPA's request for further information, Part 2
Year: 2013
Teagasc's response, dated 11 April 2012, to EPA's request for further information, Part 1
Year: 2013
EPA letter to Teagasc, issued 4 April 2012, requesting further information
Year: 2013
The following information note sets out how persons may make a representation to the EPA in response to a newspaper notice under Part II of the GMO (Deliberate Release) Regulations, S.I. No. 500 of 2003.
Letter to Teagasc from EPA requesting further information, January 2013
Year: 2013
Letter to Teagasc in March 2012 re GM Potato Field Trial